Ojjaara helps patients with myelofibrosis by reducing spleen size, easing symptoms, and improving anemia to boost independence from blood transfusions.
Dr. Francesca Palandri
Advertisement
Dr. Francesca Palandri is a medical doctor at the University of Bologna in Italy
Articles by Dr. Francesca Palandri
An expert highlights the impact of anemia in myelofibrosis and presented Ojjaara as a possible treatment to reduce transfusions and improve outcomes.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
Kisqali Plus Aromatase Inhibitor Shows Long-Term Benefit in Early Breast Cancer
2
Tagrisso Plus Chemo Offers Survival benefit in EGFR+ NSCLC
3
Imfinzi Not Associated With Bladder Cancer Quality of Life Decline
4
Lenvima Combo Fails to Extend Survival in Esophageal Cancer
5
